BioNTech (BNTX)
(Real Time Quote from BATS)
$87.24 USD
+0.53 (0.61%)
Updated Apr 26, 2024 10:04 AM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/6/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | 2.05 |
Last EPS Surprise | -22.35% |
ABR | 2.43 |
Earnings ESP
|
205.25% |
---|---|
Current Year | -1.73 |
Next Year | -1.45 |
EPS (TTM) | 4.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 785.70M | 171.43M | 2.95B | 2.85B |
# of Estimates | 4 | 4 | 5 | 5 |
High Estimate | 1.34B | 294.27M | 3.29B | 4.00B |
Low Estimate | 207.66M | 109.93M | 2.33B | 1.77B |
Year ago Sales | 1.37B | 182.56M | 4.12B | 2.95B |
Year over Year Growth Est. | -42.65% | -6.10% | -28.45% | -3.37% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -1.97 | -1.73 | -1.45 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | 1.26 | -1.99 | -2.15 | -0.12 |
High Estimate | 1.26 | -1.20 | -0.60 | 4.54 |
Low Estimate | -2.13 | -2.51 | -2.73 | -5.43 |
Year ago EPS | 2.20 | -0.86 | 4.15 | -1.73 |
Year over Year Growth Est. | -118.64% | -129.07% | -141.69% | 16.36% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 1 |
Down Last 60 Days | 2 | 2 | 6 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -1.97 | -1.73 | -1.45 |
7 Days Ago | -0.41 | -1.97 | -1.73 | -1.45 |
30 Days Ago | -0.47 | -2.23 | -1.52 | -0.70 |
60 Days Ago | -0.11 | -2.28 | -0.49 | -0.62 |
90 Days Ago | -0.11 | -2.28 | 0.12 | -0.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.43 | -1.90 | -1.83 | -1.74 |
Zacks Consensus Estimate | -0.41 | -1.97 | -1.73 | -1.45 |
Earnings ESP | 205.25% | 3.46% | -5.66% | -20.01% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.05 | 0.73 | -0.86 | 2.20 | NA |
Estimate | 2.64 | -0.53 | -0.75 | 0.18 | NA |
Difference | -0.59 | 1.26 | -0.11 | 2.02 | 0.65 |
Surprise | -22.35% | 237.74% | -14.67% | 1,122.22% | 330.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more